BlackRock Fund Advisors’s Fortress Biotech FBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding FBIO
ACA
BIT
CAM
BIM
BlackRock Fund Advisors's FBIO Position: Q4 2016 in Review
BlackRock Fund Advisors increased its Fortress Biotech (FBIO) stake by 17% in Q4 2016, buying an estimated $404K and bringing the position to 72,896 shares worth $2.95M. The position accounts for ﹤0.01% of the portfolio, ranked #3086.
BlackRock Fund Advisors first reported a position in FBIO in Q2 2013 and has held it in 15 quarters since. The position peaked at $5.03M in Q3 2013. 51 funds tracked by Wall St. Rank hold FBIO as of Q4 2016.
- BlackRock Fund Advisors held 72,896 shares of Fortress Biotech worth $2.95M as of Q4 2016.
- BlackRock Fund Advisors bought 10,799 Fortress Biotech shares in Q4 2016, an estimated $404K.
- Fortress Biotech made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3086 holding.
- BlackRock Fund Advisors first reported a position in Fortress Biotech in Q2 2013 and has held it in 15 quarters since.
- BlackRock Fund Advisors's Fortress Biotech position peaked at $5.03M in Q3 2013.
- 51 funds tracked by Wall St. Rank held Fortress Biotech as of Q4 2016.
Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.